These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 24236707)

  • 1. The America Invents Act: summarizing the statute.
    Calkins J
    Pharm Pat Anal; 2012 Mar; 1(1):13-6. PubMed ID: 24236707
    [No Abstract]   [Full Text] [Related]  

  • 2. The America Invents Act implementation.
    Hollinger S
    Expert Opin Ther Pat; 2013 May; 23(5):545-8. PubMed ID: 23560953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trade secret protection in the pharma industry.
    Armstrong M
    Pharm Pat Anal; 2016 Sep; 5(5):285-8. PubMed ID: 27572950
    [No Abstract]   [Full Text] [Related]  

  • 4. Obtaining, challenging and enforcing pharmaceutical patents under the America Invents Act.
    Genieser LH; McCann CE
    Pharm Pat Anal; 2012 Sep; 1(4):415-26. PubMed ID: 24236880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. USA-Morocco deal may extend drug patents to 30 years.
    Ahmad K
    Lancet; 2003 Dec; 362(9399):1904. PubMed ID: 14672079
    [No Abstract]   [Full Text] [Related]  

  • 6. Should the patent system for new medicines be abolished?
    DiMasi JA; Grabowski HG
    Clin Pharmacol Ther; 2007 Nov; 82(5):488-90. PubMed ID: 17952100
    [No Abstract]   [Full Text] [Related]  

  • 7. First-to-invent versus first-to-file: impact of the AIA.
    Rachinsky T; Sullivan C; Ghosh S; Resnick DS; Burton C; Armstrong M; Hanish JP; Sklan A
    Pharm Pat Anal; 2014 Jul; 3(4):353-9. PubMed ID: 25291309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obama signs America Invents Act.
    Bruce I
    Future Med Chem; 2011 Nov; 3(15):1861. PubMed ID: 22132449
    [No Abstract]   [Full Text] [Related]  

  • 9. Protecting Pharmaceutical Patents and Test Data: How the Trans-Pacific Partnership Agreement Could Affect Access to Medicines in the US and Abroad.
    Luo J; Kesselheim AS
    AMA J Ethics; 2016 Jul; 18(7):727-35. PubMed ID: 27437823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intellectual property law in Israel, and US and European objections: Market exclusivity vs. data exclusivity.
    Morag-Sela T; Cohn I; Kowalski TJ; Jarecki-Black J; Clyde-Watson Z
    Nat Biotechnol; 2004 Dec; 22(12):1591-2. PubMed ID: 15583670
    [No Abstract]   [Full Text] [Related]  

  • 11. US courts narrow patent exemptions.
    Fox JL
    Nat Biotechnol; 2003 Aug; 21(8):834. PubMed ID: 12894182
    [No Abstract]   [Full Text] [Related]  

  • 12. Patent owner options for correcting errors in US patents after grant.
    Armstrong M
    Pharm Pat Anal; 2014 Sep; 3(5):499-508. PubMed ID: 25374319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biosimilar Makers Hope Court Starts 6-Month Wait Sooner.
    Silverman E
    Manag Care; 2017 Mar; 26(3):31. PubMed ID: 28510518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmaceuticals and medical devices: business practices.
    ; Steiner DJ
    Issue Brief Health Policy Track Serv; 2012 Jan; ():1-35. PubMed ID: 22423396
    [No Abstract]   [Full Text] [Related]  

  • 15. Merck v. Integra: Supreme Court permits use of patented compounds to obtain Food and Drug Administration approvals.
    Manthei JR; Hathaway CR; Grant MA; Chung DD
    Food Drug Law J; 2006; 61(2):273-7. PubMed ID: 16903032
    [No Abstract]   [Full Text] [Related]  

  • 16. Essential AIDS medications in India.
    Thomas J
    Issues Med Ethics; 2000; 8(2):62. PubMed ID: 16323350
    [No Abstract]   [Full Text] [Related]  

  • 17. Post-Therasense inequitable conduct: a pharmaceutical perspective.
    Carson PA; Forchheimer D; Draper DN
    Pharm Pat Anal; 2013 Jul; 2(4):467-79. PubMed ID: 24237124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rx: higher prices.
    Kosterlitz J
    Natl J (Wash); 1993 Feb; 25(7):396-9. PubMed ID: 10125572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of India's new patents law 2005: a physician's perspective.
    Lele RD
    J Assoc Physicians India; 2005 Aug; 53():671-5. PubMed ID: 16398073
    [No Abstract]   [Full Text] [Related]  

  • 20. Protection of commercial opportunity.
    Wyllie MG
    BJU Int; 2012 Feb; 109(3):E8-9. PubMed ID: 22243668
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.